Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm

BackgroundLung cancer screening using low-dose computed tomography (LDCT) often leads to unnecessary biopsy because of the low specificity among patients with pulmonary nodules ≤10 mm. Circulating genetically abnormal cells (CACs) can be used to discriminate lung cancer from benign lung disease. To...

Full description

Bibliographic Details
Main Authors: Maosong Ye, Xiaoxuan Zheng, Xin Ye, Juncheng Zhang, Chuoji Huang, Zilong Liu, Meng Huang, Xianjun Fan, Yanci Chen, Botao Xiao, Jiayuan Sun, Chunxue Bai
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.638223/full
_version_ 1818914788028186624
author Maosong Ye
Xiaoxuan Zheng
Xiaoxuan Zheng
Xin Ye
Xin Ye
Xin Ye
Juncheng Zhang
Juncheng Zhang
Chuoji Huang
Chuoji Huang
Zilong Liu
Meng Huang
Meng Huang
Xianjun Fan
Xianjun Fan
Yanci Chen
Yanci Chen
Botao Xiao
Jiayuan Sun
Jiayuan Sun
Chunxue Bai
author_facet Maosong Ye
Xiaoxuan Zheng
Xiaoxuan Zheng
Xin Ye
Xin Ye
Xin Ye
Juncheng Zhang
Juncheng Zhang
Chuoji Huang
Chuoji Huang
Zilong Liu
Meng Huang
Meng Huang
Xianjun Fan
Xianjun Fan
Yanci Chen
Yanci Chen
Botao Xiao
Jiayuan Sun
Jiayuan Sun
Chunxue Bai
author_sort Maosong Ye
collection DOAJ
description BackgroundLung cancer screening using low-dose computed tomography (LDCT) often leads to unnecessary biopsy because of the low specificity among patients with pulmonary nodules ≤10 mm. Circulating genetically abnormal cells (CACs) can be used to discriminate lung cancer from benign lung disease. To examine the diagnostic value of CACs in detecting lung cancer for patients with malignant pulmonary nodules ≤10 mm.MethodsIn this prospective study, patients with pulmonary nodules ≤10 mm who were detected at four hospitals in China from January 2019 to January 2020 were included. CACs were detected using fluorescence in-situ hybridization. All patients were confirmed as lung cancer or benign disease by further histopathological examination. Multivariable logistic regression models were established to detect the presence of lung cancer using CACs and other associated characteristics. Receiver operating characteristic analysis was used to evaluate the performance of CACs for lung cancer diagnosis.ResultsOverall, 125 patients were included and analyzed. When the cutoff value of CACs was >2, the sensitivity and specificity for lung cancer were 70.5 and 86.4%. Male (OR = 0.330, P = 0.005), maximum solid nodule (OR = 2.362, P = 0.089), maximum nodule located in upper lobe (OR = 3.867, P = 0.001), and CACs >2 (OR = 18.525, P < 0.001) met the P < 0.10 criterion for inclusion in the multivariable models. The multivariable logistic regression model that included the dichotomized CACs (>2 vs. ≤2) and other clinical factors (AUC = 0.907, 95% CI = 0.842–0.951) was superior to the models that only considered dichotomized CACs or other clinical factors and similar to the model with numerical CACs and other clinical factors (AUC = 0.913, 95% CI = 0.850–0.956).ConclusionCACs presented a significant diagnostic value in detecting lung cancer for patients with pulmonary nodules ≤10 mm.
first_indexed 2024-12-19T23:51:57Z
format Article
id doaj.art-10e13817ffa74410b2537c329f896668
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-19T23:51:57Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-10e13817ffa74410b2537c329f8966682022-12-21T20:01:06ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-03-011110.3389/fonc.2021.638223638223Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mmMaosong Ye0Xiaoxuan Zheng1Xiaoxuan Zheng2Xin Ye3Xin Ye4Xin Ye5Juncheng Zhang6Juncheng Zhang7Chuoji Huang8Chuoji Huang9Zilong Liu10Meng Huang11Meng Huang12Xianjun Fan13Xianjun Fan14Yanci Chen15Yanci Chen16Botao Xiao17Jiayuan Sun18Jiayuan Sun19Chunxue Bai20Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Respiratory Endoscopy, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, ChinaJoint Research Center of Liquid Biopsy in Guangdong, Hong Kong, and Macao, Zhuhai, ChinaZhuhai Sanmed Biotech Ltd., Zhuhai, ChinaSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou, ChinaJoint Research Center of Liquid Biopsy in Guangdong, Hong Kong, and Macao, Zhuhai, ChinaZhuhai Sanmed Biotech Ltd., Zhuhai, ChinaJoint Research Center of Liquid Biopsy in Guangdong, Hong Kong, and Macao, Zhuhai, ChinaZhuhai Sanmed Biotech Ltd., Zhuhai, ChinaDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaJoint Research Center of Liquid Biopsy in Guangdong, Hong Kong, and Macao, Zhuhai, ChinaZhuhai Sanmed Biotech Ltd., Zhuhai, ChinaJoint Research Center of Liquid Biopsy in Guangdong, Hong Kong, and Macao, Zhuhai, ChinaZhuhai Sanmed Biotech Ltd., Zhuhai, ChinaJoint Research Center of Liquid Biopsy in Guangdong, Hong Kong, and Macao, Zhuhai, ChinaZhuhai Sanmed Biotech Ltd., Zhuhai, ChinaSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou, ChinaDepartment of Respiratory Endoscopy, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, ChinaDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaBackgroundLung cancer screening using low-dose computed tomography (LDCT) often leads to unnecessary biopsy because of the low specificity among patients with pulmonary nodules ≤10 mm. Circulating genetically abnormal cells (CACs) can be used to discriminate lung cancer from benign lung disease. To examine the diagnostic value of CACs in detecting lung cancer for patients with malignant pulmonary nodules ≤10 mm.MethodsIn this prospective study, patients with pulmonary nodules ≤10 mm who were detected at four hospitals in China from January 2019 to January 2020 were included. CACs were detected using fluorescence in-situ hybridization. All patients were confirmed as lung cancer or benign disease by further histopathological examination. Multivariable logistic regression models were established to detect the presence of lung cancer using CACs and other associated characteristics. Receiver operating characteristic analysis was used to evaluate the performance of CACs for lung cancer diagnosis.ResultsOverall, 125 patients were included and analyzed. When the cutoff value of CACs was >2, the sensitivity and specificity for lung cancer were 70.5 and 86.4%. Male (OR = 0.330, P = 0.005), maximum solid nodule (OR = 2.362, P = 0.089), maximum nodule located in upper lobe (OR = 3.867, P = 0.001), and CACs >2 (OR = 18.525, P < 0.001) met the P < 0.10 criterion for inclusion in the multivariable models. The multivariable logistic regression model that included the dichotomized CACs (>2 vs. ≤2) and other clinical factors (AUC = 0.907, 95% CI = 0.842–0.951) was superior to the models that only considered dichotomized CACs or other clinical factors and similar to the model with numerical CACs and other clinical factors (AUC = 0.913, 95% CI = 0.850–0.956).ConclusionCACs presented a significant diagnostic value in detecting lung cancer for patients with pulmonary nodules ≤10 mm.https://www.frontiersin.org/articles/10.3389/fonc.2021.638223/fulllung cancerpulmonary noduleearly detectionearly diagnosiscirculating genetically abnormal cell (CAC)
spellingShingle Maosong Ye
Xiaoxuan Zheng
Xiaoxuan Zheng
Xin Ye
Xin Ye
Xin Ye
Juncheng Zhang
Juncheng Zhang
Chuoji Huang
Chuoji Huang
Zilong Liu
Meng Huang
Meng Huang
Xianjun Fan
Xianjun Fan
Yanci Chen
Yanci Chen
Botao Xiao
Jiayuan Sun
Jiayuan Sun
Chunxue Bai
Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm
Frontiers in Oncology
lung cancer
pulmonary nodule
early detection
early diagnosis
circulating genetically abnormal cell (CAC)
title Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm
title_full Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm
title_fullStr Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm
title_full_unstemmed Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm
title_short Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm
title_sort circulating genetically abnormal cells add non invasive diagnosis value to discriminate lung cancer in patients with pulmonary nodules ≤10 mm
topic lung cancer
pulmonary nodule
early detection
early diagnosis
circulating genetically abnormal cell (CAC)
url https://www.frontiersin.org/articles/10.3389/fonc.2021.638223/full
work_keys_str_mv AT maosongye circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT xiaoxuanzheng circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT xiaoxuanzheng circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT xinye circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT xinye circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT xinye circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT junchengzhang circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT junchengzhang circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT chuojihuang circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT chuojihuang circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT zilongliu circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT menghuang circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT menghuang circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT xianjunfan circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT xianjunfan circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT yancichen circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT yancichen circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT botaoxiao circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT jiayuansun circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT jiayuansun circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm
AT chunxuebai circulatinggeneticallyabnormalcellsaddnoninvasivediagnosisvaluetodiscriminatelungcancerinpatientswithpulmonarynodules10mm